Improving Therapeutic Interventions of Schizophrenia with Advances in Stem Cell Technology.

ABSTRACT: Although historic documents posit schizophrenia to the beginnings of mankind, its diagnosis remains poorly defined, currently relying on unspecific clinical symptoms; and controversies still maintain its origin under intense debate. This review aimed at quantitatively assessing the preferential forefronts of clinical trials towards the treatment of schizophrenia from inception till present, according to clinicaltrials.gov database registry. Towards that end study status and study phase classifications were used as criteria for progress in the field. Study groups by sex and age together with countries and organisms involved in the studies were used as indicators of the populations studied and as evidence of main promoter institutions, in both, pharmacological and drug-free protocols. The fi

SUBMITTER: Oltra JAE 

PROVIDER: S-EPMC7383010 | biostudies-literature | 2020 Aug

REPOSITORIES: biostudies-literature